JCAD Editor in Chief James Del Rosso, DO discusses advantages of a recently approved topical minocycline foam for acne vulgaris.
JCAD Editor in Chief Jim Del Rosso, DO, discusses characteristics...
Read More
JCAD Editor in Chief Jim Del Rosso, DO, discusses diagnosing...
Read MoreJCAD Editor in Chief Jim Del Rosso, DO, on advances in tetracyclines for acne vulgaris that reduce unwanted effects of other antibiotic agents, including esophageal and gastrointestinal symptoms, dizziness, and candidiasis.
JCAD Editor in Chief Jim Del Rosso, DO, discusses the importance of capturing a consistent and complete disease history for patients with atopic dermatitis in order to secure insurance coverage for optimal treatments for each patient.
JCAD Editor in Chief Jim Del Rosso, DO, reports from Kona, Hawaii during the 2020 Winter Clinical Dermatology conference to discuss new strategies and treatment methods for preventing antibiotic resistance in patients with acne vulgaris
JCAD Editor in Chief Jim Del Rosso, DO, reports from the 2020 Winter Clinical Dermatology conference to discuss microencapsulation of active ingredients in topical formulations and the host of benefits that accompanies this new technology.
